Cancer Chemotherpy Drug Manual

1.4K installs
Ratings not yet available
270 monthly active users
$<10K monthly revenue est.
IAP 100% · Ad 0%
Install Trends
Weekly +11
Steady
Monthly +35
Steady

Cancer Chemotherpy Drug Manual Summary

Cancer Chemotherpy Drug Manual is a with in-app purchases Android app in Medical by Skyscape Medpresso Inc. Released in Feb 2025 (1 year ago). It has about 1.4K+ installs Based on AppGoblin estimates, it reaches roughly 270 monthly active users and generates around $<10K monthly revenue (100% IAP / 0% ads). Store metadata: updated Jan 31, 2026.

Recent activity: 11 installs this week (35 over 4 weeks) showing below average growth View trends →

Store info: Last updated on Google Play on Jan 31, 2026 .


0★

Ratings: 0

5★
4★
3★
2★
1★

Screenshots

App screenshot
App screenshot
App screenshot
App screenshot

App Description

Crucial manual for clinicians in cancer treatment, features over 100 drugs

"Try before you buy" - Download the FREE App, which includes sample content. In-App purchase required to unlock all content.

The Physicians' Cancer Chemotherapy Drug Manual, updated for 2024, is an essential resource for iPhone, iPad, and Android users. It features over 100 drugs, including 12 new FDA-approved agents, updated indications, and comprehensive information on dosages, toxicities, and chemotherapy regimens for major cancers. This manual is crucial for clinicians in cancer treatment.

Your must-have Physicians' Cancer Chemotherapy Drug Manual is available for your iPhone, iPad, and Android

Completely revised and updated for 2024, the Physicians' Cancer Chemotherapy Drug Manual is an up-to-date guide to the latest information on standard therapy and recent advances in the field. Written by world-class experts in clinical cancer therapeutics, this essential reference provides a complete, easy-to-use catalogue of over 100 drugs and commonly used drug regimens-both on- and off-label-for the treatment of all the major cancers.

Key Features:
• Includes 12 new agents and several new supplemental indications that have all been approved by the FDA within the past year
• Updated new indications for previously approved agents
• Indications, drug doses and schedules, toxicities, and special considerations for each agent expanded and revised
• A specific chapter focused on antiemetic treatment regimens for both acute and delayed nausea/vomiting
• Diagrams of drug structures and pathways for many of the agents
• A comprehensive discussion of clinical pharmacology, special considerations, indications, and dosages
• Covers toxicity and drug-drug interactions
• A section on chemotherapy regimens for all major cancers
• Provides an overview of the basic principles of cancer drug therapy

Content licensed from printed edition ISBN 10: 1284000001
Content licensed from printed edition ISBN 13: 9781284000009

SUBSCRIPTION :
Please purchase a yearly auto-renewing subscription to receive content access and available updates.

Yearly auto-renewing payments- $39.99

Payment will be charged to your mode of payment you select at confirmation of purchase. Subscription automatically renews unless auto-renew is turned off at least 24-hours before the end of the current period. Subscription may be managed by the user and auto-renewal can be disabled at any time by going to your App “Settings” and tapping “Manage Subscriptions”. Any unused portion of a free trial period will be forfeited when you purchase a subscription, where applicable.

If you have any questions or comments, email us any time: customersupport@skyscape.com or call 508-299-3000

Privacy Policy - https://www.skyscape.com/terms-of-service/privacypolicy.aspx
Terms and Conditions - https://www.skyscape.com/terms-of-service/licenseagreement.aspx

Author(s): Edward Chu, MD; Vincent T. DeVita Jr., MD
Publisher: Jones & Bartlett Learning